Ocular Therapeutix (OCUL) Total Liabilities (2013 - 2026)

Ocular Therapeutix's Total Liabilities history runs 14 years deep, the most recent figure standing at $151.0 million for Q1 2026.

• In Q1 2026, Total Liabilities rose 7.83% year-over-year to $151.0 million; the TTM figure through Mar 2026 stood at $151.0 million (up 7.83% YoY), while the FY2025 annual figure was $153.7 million, up 7.82% from the prior year.
• Total Liabilities was $151.0 million for Q1 2026 at Ocular Therapeutix, down from $153.7 million in the prior quarter.
• In the past five years, Total Liabilities ranged from a high of $160.9 million in Q4 2023 to a low of $107.3 million in Q2 2022.
• Historically, Total Liabilities has averaged $134.7 million across 5 years, with a median of $139.4 million in 2024.
• The sharpest annual moves came in 2022 and 2023: Total Liabilities tumbled 32.45% in 2022, then soared 41.28% in 2023.
• A 5-year view of Total Liabilities shows it stood at $113.9 million in 2022, then jumped by 41.28% to $160.9 million in 2023, then fell by 11.4% to $142.6 million in 2024, then climbed by 7.82% to $153.7 million in 2025, then slipped by 1.82% to $151.0 million in 2026.
• The last three Total Liabilities figures came in at $151.0 million (Q1 2026), $153.7 million (Q4 2025), and $152.7 million (Q3 2025), per Business Quant data.